Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negoro

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Circulation|February 7, 2001
Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interactionS Negoro, H Oh, E Tone, et al.
Cytokine|October 12, 2000
gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulationE Tone, K Kunisada, A Kumanogoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1994
[Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer]A Yokoyama, Y Kurita, K Watanabe, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II studyM Takada, S Negoro, S Kudo, et al.
Cancer|January 1, 1996
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West JapanN Katakami, M Takada, S Negoro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)]M Fukuoka, S Negoro, S Kudo, et al.
Cancer Research|January 1, 1985
Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiationT Sugimoto, T Sawada, S Negoro, et al.
Nihon Gan Chiryo Gakkai Shi|June 20, 1987
[Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon]S Ryu, M Fukuoka, S Tamai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancerN Masuda, S Negoro, S Kudoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer. CPT-11 Lung Cancer Study Group]K Nagao, M Fukuoka, A Fujita, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Circulation|February 7, 2001
Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interactionS Negoro, H Oh, E Tone, et al.
Cytokine|October 12, 2000
gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulationE Tone, K Kunisada, A Kumanogoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1994
[Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer]A Yokoyama, Y Kurita, K Watanabe, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II studyM Takada, S Negoro, S Kudo, et al.
Cancer|January 1, 1996
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West JapanN Katakami, M Takada, S Negoro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)]M Fukuoka, S Negoro, S Kudo, et al.
Cancer Research|January 1, 1985
Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiationT Sugimoto, T Sawada, S Negoro, et al.
Nihon Gan Chiryo Gakkai Shi|June 20, 1987
[Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon]S Ryu, M Fukuoka, S Tamai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancerN Masuda, S Negoro, S Kudoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer. CPT-11 Lung Cancer Study Group]K Nagao, M Fukuoka, A Fujita, et al.
Pageof 20